Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Lazar David E. | Mar 23, 2026 | Sell | - | 196,800 |
| Director | Lazar David E. | Mar 23, 2026 | Sell | - | 700,000 |
| 10% Owner | Anderson Glen R. | Aug 14, 2023 | Buy | $56.01K | 23,934 |
| 10% Owner | Anderson Glen R. | Aug 11, 2023 | Buy | $74.34K | 35,064 |
| 10% Owner | Anderson Glen R. | Aug 10, 2023 | Buy | $86.05K | 44,354 |
| Chief Medical Officer | Litchev Boyan Vesselinov | Dec 1, 2022 | Buy | $935.45 | 500 |
| Chief Medical Officer | Litchev Boyan Vesselinov | Nov 22, 2022 | Buy | $915 | 500 |
| CEO | Meckler Jeffrey A | Nov 21, 2022 | Buy | $18.24K | 9,600 |
| CEO | Meckler Jeffrey A | Nov 18, 2022 | Buy | $705.48 | 400 |
| CEO | Meckler Jeffrey A | Sep 8, 2022 | Buy | $28.86K | 10,308 |
| Chief Business Officer | Linscott Walt Addison | Sep 7, 2022 | Buy | $393 | 150 |
| CEO | Meckler Jeffrey A | Sep 7, 2022 | Buy | $22.18K | 8,632 |
| CEO | Meckler Jeffrey A | Sep 6, 2022 | Buy | $2.59K | 1,060 |
| CEO | Meckler Jeffrey A | Jun 6, 2022 | Buy | $51.88K | 19,727 |
| Chief Medical Officer | Litchev Boyan Vesselinov | Mar 2, 2022 | Buy | $204.63 | 50 |
| Director | Newman Michael James | Feb 1, 2022 | Sell | $70.69K | 14,130 |
| Chief Medical Officer | Litchev Boyan Vesselinov | Jan 31, 2022 | Buy | $465 | 100 |
| Director | Newman Michael James | Jan 31, 2022 | Sell | $29.35K | 5,870 |
| CEO | Meckler Jeffrey A | Nov 18, 2021 | Buy | $65.11K | 11,187 |
| CEO | Meckler Jeffrey A | Sep 14, 2021 | Buy | $84K | 12,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.